Corbus Pharmaceuticals Holdings, Inc. (CRBP) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CRBP Revenue Growth
CRBP Revenue Analysis (2014–2025)
As of May 8, 2026, Corbus Pharmaceuticals Holdings, Inc. (CRBP) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, CRBP's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $36.1 million in 2019.
When compared to Healthcare sector peers including AGIO (+78.3% YoY), RCUS (+67.4% YoY), and ARQT (+95.3% YoY). Compare CRBP vs AGIO →
CRBP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CRBPCurrent | $0 | - | - | - | |
 AGIO | $54M | +78.3% | - | -873.9% | |
 RCUS | $247M | +67.4% | +25.9% | -156.3% | |
 ARQT | $376M | +95.3% | - | -3.3% |
CRBP Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-233,000 | - | $-85,310,000 | - |
| 2024 | $0 | - | $-600,000 | - | $-48,721,000 | - |
| 2023 | $0 | - | $0 | - | $-45,078,000 | - |
| 2022 | $0 | -100.0% | $-1,487,853 | - | $-34,835,445 | - |
| 2021 | $882K | -77.6% | $-757,527 | -85.9% | $-55,989,024 | -6350.1% |
| 2020 | $3.9M | -89.1% | $3.9M | 100.0% | $-122,810,233 | -3119.2% |
| 2019 | $36.1M | +649.5% | $-53,461,222 | -147.9% | $-77,104,579 | -213.3% |
| 2018 | $4.8M | +97.6% | $-43,791,685 | -908.1% | $-56,747,707 | -1176.8% |
| 2017 | $2.4M | +27.7% | $-23,598,770 | -967.1% | $-32,562,816 | -1334.4% |
| 2016 | $1.9M | +194.8% | $-13,525,311 | -707.6% | $-19,985,058 | -1045.6% |
See CRBP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRBP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRBP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRBP — Frequently Asked Questions
Quick answers to the most common questions about buying CRBP stock.
Is CRBP's revenue growth accelerating or slowing?
CRBP TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is CRBP's long-term revenue growth rate?
Corbus Pharmaceuticals Holdings, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CRBP's revenue distributed by segment?
CRBP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.